Akshat Jain M.D., M.P.H./LinkedIn
Dec 20, 2025, 16:13
Akshat Jain Explains VWF/FVIII Prophylaxis in Children Under 6
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:
”Plasma-derived VWF/FVIII prophylaxis in children under 6 with VWD: first results from WIL-33 presented at American Society of Hematology meeting 2025.
Very excited to share this science and pharmacokinetics based guidance on how to treat children under 6 yrs of age with this common bleeding disorder, first time ever !
Watch the full interview here.
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?